SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K. Rajender Reddy, Amina Wirjosemito, Tanya M. Pavri, Lorie Sinese, HCV Therapy With Daclatasvir, PEG-IFN, and RBV After Boceprevir-Based Therapy Failure Post-Liver Transplantation in Hyper-IgM Syndrome, Transplantation, 2014, 97, 8, e47

    CrossRef

  2. 2
    H.M. Dabbous, M.S. Elmeteini, M.A. Sakr, I.F. Montasser, M. Bahaa, A. Abdelaal, M. Fathy, R. Refaie, M. Seyam, A. Abdelmonem, A. Mukhtar, N. Hegazy, M. Almoneiri, Optimizing Outcome of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplantation: Moving Forward by Looking Back, Transplantation Proceedings, 2014, 46, 3, 822

    CrossRef

  3. 3
    Y. Yoshida, T. Ikegami, T. Yoshizumi, T. Toshima, Y.-I. Yamashita, S. Yoshiya, K. Shirabe, Y. Maehara, rs8099917 and Viral Genotyping as Indications for Living Donor Liver Transplantation for Hepatitis C: A Case Report, Transplantation Proceedings, 2014,

    CrossRef

  4. 4
    Adriano M. Pellicelli, Marzia Montalbano, Raffaella Lionetti, Christine Durand, Peter Ferenci, Gianpiero D’Offizi, Viola Knop, Andrea Telese, Ilaria Lenci, Arnaldo Andreoli, Stefan Zeuzem, Mario Angelico, Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late, Digestive and Liver Disease, 2014,

    CrossRef

  5. 5
    Elizabeth C. Verna, Rita Abdelmessih, Marcela A. Salomao, Jay Lefkowitch, Roger K. Moreira, Robert S. Brown, Cholestatic hepatitis C following liver transplantation: An outcome-based histological definition, clinical predictors, and prognosis, Liver Transplantation, 2013, 19, 1
  6. 6
    Toru Ikegami, Ken Shirabe, Takasuke Fukuhara, Norihiro Furusyo, Kazuhiro Kotoh, Masaki Kato, Shinji Shimoda, Shinichi Aishima, Yuji Soejima, Tomoharu Yoshizumi, Yoshihiko Maehara, Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living-donor liver transplantation, Hepatology Research, 2013, 43, 6
  7. 7
    Giacomo Germani, Emmanuel Tsochatzis, Vasilios Papastergiou, Andrew K Burroughs, HCV in liver transplantation, Seminars in Immunopathology, 2013, 35, 1, 101

    CrossRef

  8. 8
    Marina Berenguer, Geoffrey McCaughan, Hepatitis C Virus–Associated Cholestatic Hepatitis: We Cannot Seem to Agree on Diagnostic Criteria, Liver Transplantation, 2013, 19, 2
  9. 9
    Marcela Salomao, Elizabeth C. Verna, Jay H. Lefkowitch, Roger K. Moreira, Histopathologic Distinction Between Fibrosing Cholestatic Hepatitis C and Biliary Obstruction, The American Journal of Surgical Pathology, 2013, 37, 12, 1837

    CrossRef

  10. 10
    Eunsil Yu, Histopathological Features of Late Liver Allograft Dysfunction, The Journal of the Korean Society for Transplantation, 2013, 27, 4, 153

    CrossRef

  11. 11
    Andres Duarte-Rojo, Vikram Budhraja, Bart J. Veldt, David D. Goldstein, Kymberly D. Watt, Julie K. Heimbach, John G. McHutchison, Hans L. Tillman, John J. Poterucha, Michael R. Charlton, Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: A case-control study and literature review, Liver Transplantation, 2013, 19, 12
  12. 12
    Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert, Intrahepatic cholestasis in common chronic liver diseases, European Journal of Clinical Investigation, 2013, 43, 10
  13. 13
    Mark W. Russo, Tarun Narang, Lon Eskind, Daniel Hayes, Vincent Casingal, Preston P. Purdum, John S. Hanson, Will Ahrens, James Norton, Herbert Bonkovsky, Intravenous Interferon Administered During Liver Transplantation Is Not Effective in Preventing Hepatitis C Reinfection, Digestive Diseases and Sciences, 2013, 58, 10, 3010

    CrossRef

  14. 14
    Bita V. Naini, Charles R. Lassman, Liver Transplant Pathology, Surgical Pathology Clinics, 2013, 6, 2, 277

    CrossRef

  15. 15
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  16. 16
    Geeta S. Karnik, Kirti Shetty, Management of Recurrent Hepatitis C in Orthotopic Liver Transplant Recipients, Infectious Disease Clinics of North America, 2013, 27, 2, 285

    CrossRef

  17. 17
    Jennifer C. Price, Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation, Current Hepatitis Reports, 2013, 12, 4, 227

    CrossRef

  18. 18
    R. J. Fontana, E. A. Hughes, M. Bifano, H. Appelman, D. Dimitrova, R. Hindes, W. T. Symonds, Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C, American Journal of Transplantation, 2013, 13, 6
  19. 19
    Roger K. Moreira, Marcela Salomao, Elizabeth C. Verna, Robert S. Brown, Jay H. Lefkowitch, The Hepatitis Aggressiveness Score (HAS), The American Journal of Surgical Pathology, 2013, 37, 1, 104

    CrossRef

  20. You have free access to this content20
    K. Rajender Reddy, Gregory T. Everson, Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation, Hepatology, 2013, 58, 3
  21. 21
    Natalie M. Bachir, Anne M. Larson, Adult Liver Transplantation in the United States, The American Journal of the Medical Sciences, 2012, 343, 6, 462

    CrossRef

  22. 22
    Robert J. Fontana, Eric A. Hughes, Henry Appelman, Robert Hindes, Dessislava Dimitrova, Marc Bifano, Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation, Liver Transplantation, 2012, 18, 9
  23. 23
    Ivo W. Graziadei, Heinz M. Zoller, Anna Schloegl, Karin Nachbaur, Karl-Peter Pfeiffer, Walter Mark, Gregor Mikuz, Johann Pratschke, Raimund Margreiter, Wolfgang Vogel, Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation, Liver Transplantation, 2012, 18, 6
  24. 24
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  25. 25
    Norah Terrault, Liver transplantation in the setting of chronic HCV, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 531

    CrossRef

  26. 26
    Shishir Shetty, David H Adams, Stefan G Hubscher, Post-transplant liver biopsy and the immune response: lessons for the clinician, Expert Review of Clinical Immunology, 2012, 8, 7, 645

    CrossRef

  27. 27
    Lydia M. Petrovic, Recurrent diseases following liver transplantation, Current Opinion in Organ Transplantation, 2012, 17, 3, 293

    CrossRef

  28. 28
    Saleh A. Alqahtani, Update in liver transplantation, Current Opinion in Gastroenterology, 2012, 28, 3, 230

    CrossRef

  29. 29
    Saleh A Alqahtani, Anne M Larson, Adult liver transplantation in the USA, Current Opinion in Gastroenterology, 2011, 27, 3, 240

    CrossRef

  30. 30
    Eleonora De Martin, Kryssia I Rodriguez-Castro, Alessandro Vitale, Giacomo Zanus, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra, Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?, Future Virology, 2011, 6, 10, 1179

    CrossRef

  31. 31
    A. Rubín, V. Aguilera, M. Berenguer, Liver transplantation and hepatitis C, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 805

    CrossRef

  32. 32
    Reddy K Rajender, Chalermrat Bunchorntavakul, Managing hepatitis C: Before and after liver transplantation, Indian Journal of Transplantation, 2011, 5, 2, 72

    CrossRef

  33. 33
    A. Sidney Barritt, Jama M. Darling, Paul H. Hayashi, New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation, Current Hepatitis Reports, 2011, 10, 3, 179

    CrossRef

  34. 34
    Stefan G. Hübscher, What is the long-term outcome of the liver allograft?, Journal of Hepatology, 2011, 55, 3, 702

    CrossRef

  35. 35
    Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi, Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease,